Table 3.
Baseline clinical characteristics of DR-TB patients stratified by lost to follow-up status, University of Gondar Comprehensive Specialized Hospital, September 2010–December 2017, (N = 332)
| Variable | Frequency (%) | Lost to follow-up status | |
|---|---|---|---|
| Eventa (n = 36) | Censoredb (n = 296) | ||
| BMI | |||
| < 18.5 | 221 (71.99) | 25 | 186 |
| > =18.50 | 86 (18.01) | 8 | 78 |
| Functional status | |||
| Working | 78 (23.49) | 7 | 71 |
| Ambulatory | 225 (67.77) | 29 | 196 |
| Bedridden | 29 (8.73) | 0 | 29 |
| Registration Group | |||
| New | 41 (12.35) | 4 | 37 |
| Relapse | 45 (13.55) | 5 | 40 |
| Return after lost to follow-up | 2 (0.60) | 1 | 1 |
| Failure | 241 (72.60) | 26 | 215 |
| outcome not assigned | 3 (0.90) | 0 | 3 |
| No of previous TB treatment | |||
| < 2 | 112 (33.74) | 11 | 101 |
| > =2 | 218 (65.66) | 25 | 193 |
| Not recorded | 2 (0.60) | 0 | 2 |
| Site of tuberculosis | |||
| Pulmonary | 306 (92.17) | 31 | 275 |
| Extra Pulmonaryc | 26 (7.83) | 5 | 21 |
| Lung complication | |||
| No complication | 275 (82.83) | 29 | 246 |
| Pneumonia | 39 (11.75) | 5 | 34 |
| Pneumothorax | 5 (1.51) | 0 | 5 |
| Corpulmonale | 9 (2.71) | 1 | 8 |
| Bronchiectasis | 4 (1.20) | 1 | 3 |
| Co-morbidity | |||
| No | 277 (83.43) | 30 | 247 |
| Yesd | 55 (16.57) | 6 | 49 |
| HIV co-infection | |||
| No | 246 (74.10) | 27 | 219 |
| Yes | 84 (25.30) | 9 | 75 |
| Unknown | 2 (0.60) | 0 | 2 |
| Base line sputum smear result | |||
| Negative | 48 (14.46) | 6 | 42 |
| Positive | 258 (77.71) | 27 | 231 |
| Not recorded | 26 (7.83) | 3 | 23 |
| Baseline Culture result | |||
| Positive | 180 (54.22) | 15 | 165 |
| Negative | 71 (21.38) | 12 | 59 |
| Not recorded | 81 (24.40) | 9 | 72 |
| Culture converted among baseline Culture result positive | |||
| Yes | 159 (88.33) | 9 | 150 |
| No | 21 (11.67) | 6 | 15 |
| DR-TB type | |||
| RR-TB | 147 (44.28) | 17 | 130 |
| MDR-TB | 168 (50.60) | 18 | 150 |
| Clinically diagnosed | 17 (5.12) | 1 | 16 |
Eventa in this study was patients lost during follow-up; Censoredb was either cured, completed, death, transfer out, still on treatment
cLymph node, vertebral, bone, testicular, and skin
dDiabetes Mellitus, Hypertension, Bronchial Asthma, CKD, and Cardiac diseases